Generation R Next - Optimaal Opgroeien

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorErasmus Medical Center

About this trial

The aim of this randomized controlled trial is to improve birth outcomes and long-term outcomes in mother and child by optimizing lifestyle,nutrition and stress experience in the preconception period and early pregnancy in women and men

The main research question that will be addressed is: Does an intervention focused on optimizing preconception and early pregnancy lifestyle, nutrition and stress improve the birth outcomes and long-term outcomes in mother and child?

Participants will receive an individual lifestyle consultation at the start of the study. Depending on their study arm, participants will receive an additional lifestyle program focused on health during preconception and early pregnancy, coping with stress and adherence to a healthy(er) lifestyle. The given advices are based on national guidelines.

Researchers will compare the intervention group and control group to see if (adherence to) this lifestyle program improve birth outcomes and long-term outcomes in mother and child.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Planning a pregnancy or early pregnancy up to < 12 weeks

With the presence of at least one of the predetermined risk factors

Residential address in the municipality of Rotterdam and expected residential address in the municipality of Rotterdam at the birth of their child

Consent for participation

Disqualifiers

Temporary or complete withdrawal from participation

Gestational age > 12+0 at study entry

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standard care

    Other intervention

    Individual lifestyle consultation

  • Lifestyle program

    Other intervention

    Lifestyle program focusing on lifestyle advice, coping with stress and adherence to a healthy(er) lifestyle. This program consists of 3 group sessions and an online platform.

Treatment groups

1,750 Participants
are divided into 2 treatment groups
Group A: Standard care and additional lifestyle programExperimental treatment 2 interventions
Group B: Standard careOther 1 intervention

Trial outcomes

Primary outcomes

1

Preterm birth

Birth of the child before 37 weeks of pregnancy

Time frame
Assessed at birth
2

Low birthweight/small-for-gestational-age

Birthweight below 10th percentile corrected for gestational age

Time frame
Assessed at birth
3

High birthweight/large-for-gestational-age

Birthweight above 90th percentile corrected for gestational age

Time frame
Assessed at birth
4

Low Apgar-score

Apgar-score assessed 5 minutes after birth, below 7 is considered as low with higher chance on worse outcome (scale: 0-10)

Time frame
Assessed at birth

Secondary outcomes

1

Adherence to lifestyle advice (mother)

Lifestyle changes assessed via questionnaires during the study period

Time frame
During pregnancy and early childhood, until 12 months
2

Sleep/wake rhythm (mother)

Sleep/wake rhythm assessed via questionnaires during the study period with the Munich Chronotype Questionnaire (MCTQ). 12 items

Time frame
During pregnancy and early childhood, until 12 months
3

Sleep/wake rhythm (mother)

Sleep/wake rhythm assessed via questionnaires during the study period with the General Sleep Disturbances Questionnaire. 22 items, responses are given on an eight-point scale ranging from 0 (no days) to 7 (every day). The total score for the scale ranges between 0 and 154, with higher scores indicating a higher frequency of sleep disturbances.

Time frame
During pregnancy and early childhood, until 12 months
4

Social support (mother)

Social support assessed via questionnaires during the study period with the Adaptive Functioning Scales Spouse/Partner. 6 items with 6-point Likert scale.

Time frame
During pregnancy and early childhood, until 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Erasmus Medical Center

Lead sponsor

INDIGO Rijnmond

Collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

Collaborator

Stichting Bevordering van Volkskracht

Collaborator

Stichting Achmea Gezondheidszor

Collaborator

Bernard van Leer Foundation

Collaborator

Ministerie van Volksgezondheid, Welzijn en Sport

Collaborator